Releaf
Releaf · page 2
- Your #1 Podcast on Cannabis News
What Cannabis Leaders Can Learn from Olympic Champions
In this special edition of the Business of Cannabis Podcast, Tim Kirby, CEO of Releaf, sits down with Professor Chris Shambrook, renowned performance psychologist and long-time advisor to the British Olympic rowing team.
- Interviews
Legal Medicine Shouldn’t Make You Feel Like a Criminal at the Airport
The UK’s Border Force and airport security services have been on high alert for cannabis coming into and out of the country for some time, following a significant spike in seizures.
- Medical Cannabis
Not on Our Watch: Releaf Pushes Back Against Rushed Cannabis Prescribing
The British Medical Association (BMA), which represents tens of thousands of General Practitioners in the UK, this week threatened new strike action amid increasing tensions with the Starmer government.
- Your #1 Podcast on Cannabis News
Podcast: Special Ed. | From Anecdote to Evidence: Data for Advanced Access | Releaf & Dr Anne Katrin Schlag
In this special edition of the Business of Cannabis Podcast, we go From Anecdote to Evidence with Dr Anne Katrin Schlag, Head of Research at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf.
- Uncategorized
Cost vs Care: Can Clinics Stay Affordable While Scaling Responsibly?
Medical cannabis clinics are often driven to scale their operations quickly, out of a desire to reach more patients who could benefit from treatment and the need to remain affordable for them. But doing so shouldn’t come at the cost of regulatory compliance.
- Your #1 Podcast on Cannabis News
Business of Cannabis: Podcast | The Broken Promise of UK Medical Cannabis – Releaf x Fieldfisher
The third in our series of guest episodes features a discussion between the CEO of Releaf, Tim Kirby, and Robert Jappie, a partner at Fieldfisher LLP specialising in regulatory law.
- Uncategorized
What Can the UK Learn From Germany’s Booming Medical Cannabis Market?
With Germany recently making some foundational changes to its medical cannabis framework, helping expand access significantly and driving a surge in patient numbers, we spoke to leading UK-based clinic Releaf to understand what structural, cultural, and clinical lessons the UK can learn from Germany’s success.
- Adult-Use
German Cannabis Law Remains Uncertain, Malta Imposes Controversial Changes, Dutch Cannabis Experiment Progresses, & More from Czech Republic
From Germany’s coalition agreement to the expansion of the Netherlands’ cannabis pilot and the Czech Republic’s medical cannabis market, industry news has managed to match the heady pace of the global news cycle.
- Your #1 Podcast on Cannabis News
Business of Cannabis: Podcast | Releaf x Glass Pharms
The second in our series of guest episodes features a discussion between CEO of Releaf, Tim Kirby, and James Duckenfield, CEO of Glass Pharms.
- Medical
Beyond Chronic Pain: Why Private Clinics are Vital to Making Medical Cannabis Mainstream
The medical cannabis industry is in a precarious situation. The fledgling market is experiencing rapid growth across Europe, indicative of surging demand.
- Opinion
The Rise and Rise of Releaf
Creating a culture that focuses on the behaviours required to achieve the results desired, has been the root cause of Releaf’s success in the UK’s medical cannabis sector – a sector that has stagnated since medical cannabis became legal in 2018.
- Medical
Compliance Meets Compassion: How Releaf’s Training Standards Set the Benchmark for Medical Cannabis in the UK
The medical cannabis sector in the UK is navigating a dual imperative: ensuring rigorous compliance with regulatory standards while delivering compassionate care to patients in need. For UK medical cannabis clinic Releaf, these two objectives are not only complementary but also foundational to its operations.
